Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,049 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction: Ambulatory management of pre- and extensively drug resistant tuberculosis patients with imipenem delivered through port-a-cath: A mixed methods study on treatment outcomes and challenges.
Chavan VV, Dalal A, Nagaraja S, Thekkur P, Mansoor H, Meneguim A, Paryani R, Singh P, Kalon S, Das M, Ferlazzo G, Isaakidis P. Chavan VV, et al. Among authors: singh p. PLoS One. 2024 Feb 21;19(2):e0299477. doi: 10.1371/journal.pone.0299477. eCollection 2024. PLoS One. 2024. PMID: 38381762 Free PMC article.
Yield of Systematic Longitudinal Screening of Household Contacts of Pre-Extensively Drug Resistant (PreXDR) and Extensively Drug Resistant (XDR) Tuberculosis Patients in Mumbai, India.
Paryani RH, Gupta V, Singh P, Verma M, Sheikh S, Yadav R, Mansoor H, Kalon S, Selvaraju S, Das M, Laxmeshwar C, Ferlazzo G, Isaakidis P. Paryani RH, et al. Among authors: singh p. Trop Med Infect Dis. 2020 May 26;5(2):83. doi: 10.3390/tropicalmed5020083. Trop Med Infect Dis. 2020. PMID: 32466438 Free PMC article.
Ambulatory management of pre- and extensively drug resistant tuberculosis patients with imipenem delivered through port-a-cath: A mixed methods study on treatment outcomes and challenges.
Chavan VV, Dalal A, Nagaraja S, Thekkur P, Mansoor H, Meneguim A, Paryani R, Singh P, Kalon S, Das M, Ferlazzo G, Isaakidis P. Chavan VV, et al. Among authors: singh p. PLoS One. 2020 Jun 16;15(6):e0234651. doi: 10.1371/journal.pone.0234651. eCollection 2020. PLoS One. 2020. PMID: 32544174 Free PMC article.
One Step Forward: Successful End-of-Treatment Outcomes of Patients With Drug-Resistant Tuberculosis Who Received Concomitant Bedaquiline and Delamanid in Mumbai, India.
Das M, Dalal A, Laxmeshwar C, Ravi S, Mamnoon F, Meneguim AC, Paryani R, Mathur T, Singh P, Mansoor H, Kalon S, Hossain FN, Lachenal N, Coutisson S, Ferlazzo G, Isaakidis P. Das M, et al. Among authors: singh p. Clin Infect Dis. 2021 Nov 2;73(9):e3496-e3504. doi: 10.1093/cid/ciaa1577. Clin Infect Dis. 2021. PMID: 33079176
Concomitant bedaquiline and delamanid therapy in patients with drug-resistant extra-pulmonary tuberculosis in Mumbai, India.
Mongia H, Mamnoon F, Silsarma A, Mahajan R, Dalal A, Galindo MA, Iyer A, Singh P, Mansoor H, Das M, Morales M, Spencer H, Isaakidis P. Mongia H, et al. Among authors: singh p. J Clin Tuberc Other Mycobact Dis. 2024 Apr 1;35:100433. doi: 10.1016/j.jctube.2024.100433. eCollection 2024 May. J Clin Tuberc Other Mycobact Dis. 2024. PMID: 38617837 Free PMC article.
Genome wide landscaping of copy number variations for horse inter-breed variability.
Sharma NK, Singh P, Saha B, Bhardwaj A, Iquebal MA, Pal Y, Nayan V, Jaiswal S, Giri SK, Legha RA, Bhattacharya TK, Kumar D, Rai A. Sharma NK, et al. Among authors: singh p. Anim Biotechnol. 2025 Dec;36(1):2446251. doi: 10.1080/10495398.2024.2446251. Epub 2025 Jan 10. Anim Biotechnol. 2025. PMID: 39791493
13,049 results
You have reached the last available page of results. Please see the User Guide for more information.